Close

Akamai (AKAM) Wins Appeal in Content Delivery Patent Case vs. Limelight (LLNW)

August 31, 2012 1:26 PM EDT
Shares of Limelight Networks (Nasdaq: LLNW) are trickling lower Friday following reporst that it is facing another round of patent litigation from peer Akamai Technologies (Nasdaq: AKAM).

According to Bloomberg, Akamai's case against Limelight was revived by the U.S. Court of Appeals for the Federal Circuit in Washington.

Akamai's claim is to online content delivery of doctor and patient communication. Currently, Limelight says it hasn't infringed on a patent unless all steps are followed. The company is being backed up by names like Apple (Nasdaq: AAPL) and Google (Nasdaq: GOOG), while pharma's like Bristol-Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) say infinging the patent would affect patient rights.

The case is Akamai Technologies v. Limelight Networks, 2009-1372, U.S. Court of Appeals for the Federal Circuit (Washington). The lower court case is Akamai Technologies v. Limelight Networks Inc. (LLNW), 06cv11109, U.S. District Court, District of Massachusetts (Boston).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Insiders' Blog, Litigation